FRONTIER CAPITAL MANAGEMENT CO LLC – BioMarin Pharmaceutical Inc. Transaction History
FRONTIER CAPITAL MANAGEMENT CO LLC portfolio value:
$64.38M
portfolio value
FRONTIER CAPITAL MANAGEMENT CO LLC quarter portfolio value change:
+2.29%
quarter
BioMarin Pharmaceutical Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +24.45% | 149.23K shares | 13.81M | $84.77 | 759.54K |
| Q2 2022 | share | Increase | +50.36% | 204.39K shares | 19.28M | $82.87 | 610.30K |
| Q1 2022 | share | Decrease | -8.74% | -38.87K shares | -8.00M | $77.1 | 405.90K |
| Q4 2021 | share | Decrease | -10.60% | -52.75K shares | 842K | $89.08 | 444.77K |
| Q3 2021 | share | Decrease | -17.93% | -108.67K shares | -12.12M | $77.29 | 497.53K |
| Q2 2021 | share | Increase | +4.35% | 25.29K shares | 6.71M | $83.44 | 606.20K |
| Q1 2021 | share | Decrease | -14.19% | -96.06K shares | -15.49M | $75.51 | 580.91K |
| Q4 2020 | share | Decrease | -29.41% | -282.00K shares | -13.59M | $87.69 | 676.98K |
| Q3 2020 | share | Increase | +27.17% | 204.91K shares | -20.04M | $76.08 | 958.98K |
| Q2 2020 | share | Decrease | -23.26% | -228.53K shares | 9.97M | $123.34 | 754.06K |
| Q1 2020 | share | Decrease | -11.28% | -124.96K shares | -10.61M | $84.5 | 982.59K |
| Q4 2019 | share | Increase | +47.11% | 354.65K shares | 42.89M | $84.55 | 1.10M |
| Q3 2019 | share | Decrease | -4.77% | -37.72K shares | -16.97M | $67.4 | 752.90K |
| Q2 2019 | share | Decrease | -27.27% | -296.38K shares | -28.84M | $85.65 | 790.62K |
| Q1 2019 | share | Decrease | -19.87% | -269.58K shares | -18.95M | $88.83 | 1.08M |
| Q4 2018 | share | Decrease | -2.02% | -27.90K shares | -18.74M | $85.15 | 1.35M |
| Q3 2018 | share | Increase | +14.38% | 174.02K shares | 20.22M | $96.97 | 1.38M |
| Q2 2018 | share | Increase | +42.75% | 362.53K shares | 45.28M | $94.2 | 1.21M |
| Q1 2018 | share | Increase | +2.33% | 19.27K shares | -5.14M | $81.07 | 847.94K |
| Q4 2017 | share | Increase | +9.53% | 72.12K shares | 3.48M | $89.17 | 828.66K |
| Q3 2017 | share | Decrease | -6.64% | -53.82K shares | -3.18M | $93.07 | 756.54K |
| Q2 2017 | share | Decrease | -0.19% | -1.51K shares | 2.33M | $90.82 | 810.37K |
| Q1 2017 | share | Increase | +4.08% | 31.83K shares | 6.64M | $87.78 | 811.88K |
| Q4 2016 | share | Increase | +11.37% | 79.66K shares | -180K | $82.84 | 780.05K |
| Q3 2016 | share | Increase | +84.81% | 321.40K shares | 35.31M | $92.52 | 700.38K |
| Q2 2016 | share | Increase | +14.63% | 48.36K shares | 2.21M | $77.8 | 378.98K |
| Q1 2016 | share | Decrease | -12.28% | -46.27K shares | -12.21M | $82.48 | 330.62K |